Atherosclerosis
Volume 176, Issue 1 , Pages 125-132 , September 2004

The short-/intermediate-term changes in novel vascular inflammatory markers after angioplasty plus stenting in patients with symptomatic advanced systemic arterial diseases

  • Wen Lieng Lee

      Affiliations

    • Division of Cardiology, Department of Medicine, Taichung Veterans General Hospital, 160, Sec. 3, Chung-Kang Road, Taichung 407, Taiwan, ROC
    • Department of Medicine, National Yang Ming University School of Medicine, Taipei, Taiwan, ROC
    • Corresponding Author InformationCorresponding author. Tel.: +886 4 2359 2525x3124; fax: +886 4 2359 9257.
    • ,
  • Wayne Huey-Herng Sheu

      Affiliations

    • Department of Education and Research, Taichung Veterans General Hospital, Taichung, Taiwan, ROC
    • Department of Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC
    • ,
  • Tsun-Jui Liu

      Affiliations

    • Division of Cardiology, Department of Medicine, Taichung Veterans General Hospital, 160, Sec. 3, Chung-Kang Road, Taichung 407, Taiwan, ROC
    • Institute of Clinical Medicine, National Yang Ming University School of Medicine, Taipei, Taiwan, ROC
    • ,
  • Wen-Jen Lee

      Affiliations

    • Department of Education and Research, Taichung Veterans General Hospital, Taichung, Taiwan, ROC
    • ,
  • Cheng-Rong Tsao

      Affiliations

    • Division of Cardiology, Department of Medicine, Taichung Veterans General Hospital, 160, Sec. 3, Chung-Kang Road, Taichung 407, Taiwan, ROC
    • ,
  • Yong-Hua Ju

      Affiliations

    • Department of Medicine, Taichung Hospital, Taichung, Taiwan, ROC
    • ,
  • Mao-Fang Liao

      Affiliations

    • Department of Medicine, Feng-Yuan Hospital, Taichung, Taiwan, ROC
    • ,
  • Ying-Tsung Chen

      Affiliations

    • Department of Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC
    • Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, ROC
    • ,
  • Chih-Tai Ting

      Affiliations

    • Division of Cardiology, Department of Medicine, Taichung Veterans General Hospital, 160, Sec. 3, Chung-Kang Road, Taichung 407, Taiwan, ROC
    • Department of Medicine, National Yang Ming University School of Medicine, Taipei, Taiwan, ROC

Received 9 July 2003 ,Revised 1 March 2004 ,Accepted 23 March 2004.

References 

  1. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N. Engl. J. Med. 2001;344:1608–1621
  2. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143
  3. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ. Res. 2001;89:763–771
  4. Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ. Res. 2001;89:1092–1103
  5. Huo Y, Ley K. Adhesion molecules and atherogenesis. Acta Physiol. Scand. 2001;173:35–43
  6. Szmitko PE, Wang CH, Weisel RD, et al.  Biomarkers of vascular disease linking inflammation to endothelial activation: Part II. Circulation. 2003;108:2041–2048
  7. Szmitko PE, Wang CH, Weisel RD, et al.  New markers of inflammation and endothelial cell activation: Part I. Circulation. 2003;108:1917–1923
  8. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001;103:491–495
  9. Hwang SJ, Ballantyne CM, Sharrett AR, et al.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1997;96:4219–4225
  10. Salomaa V, Matei C, Aleksic N, et al.  Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. Lancet. 1999;353:1729–1734
  11. Blankenberg S, Rupprecht HJ, Bickel C, et al.  Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104:1336–1342
  12. Pradhan AD, Rifai N, Ridker PM. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation. 2002;106:820–825
  13. Peter K, Nawroth P, Conradt C, et al.  Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler. Thromb. Vasc. Biol. 1997;17:505–512
  14. Blann AD, Seigneur M, Steiner M, Miller JP, McCollum CN. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb. Haemost. 1998;79:1080–1085
  15. Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb. Haemost. 1994;72:151–154
  16. Mocco J, Choudhri TF, Mack WJ, et al.  Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis. Neurosurgery. 2001;48:718–721
  17. Tsakiris DA, Tschopl M, Jager K, et al.  Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis. 1999;142:193–200
  18. Belch JJ, Shaw JW, Kirk G, et al.  The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation. 1997;95:2027–2031
  19. Phillips JW, Barringhaus KG, Sanders JM, et al.  Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation. 2003;107:2244–2249
  20. Erren M, Reinecke H, Junker R, et al.  Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler. Thromb. Vasc. Biol. 1999;19:2355–2363
  21. Fiotti N, Giansante C, Ponte E, et al.  Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis. 1999;145:51–60
  22. Vashist A, Heller EN, Brown EJ, Alhaddad IA. Renal artery stenosis: a cardiovascular perspective. Am. Heart J. 2002;143:559–564
  23. St. Goar FG, Joye JD, Laird JR. Percutaneous arterial aortoiliac intervention. J. Interv. Cardiol. 2001;14:533–537
  24. Harding SA, Walters DL, Palacios IF, Oesterle SN. Adjunctive pharmacotherapy for coronary stenting. Curr. Opin. Cardiol. 2001;16:293–299
  25. Mehta SR, Yusuf S, Peters RJ, et al.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527–533
  26. Losordo DW, Isner JM, Diaz-Sandoval LJ. Endothelial recovery: the next target in restenosis prevention. Circulation. 2003;107:2635–2637
  27. Schillinger M, Exner M, Mlekusch W, et al.  Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J. Endovasc. Ther. 2002;9:59–66
  28. Sachais BS. Platelet–endothelial interactions in atherosclerosis. Curr. Atheroscler. Rep. 2001;3:412–416
  29. Semenov AV, Romanov YA, Loktionova SA, et al.  Production of soluble P-selectin by platelets and endothelial cells. Biochemistry (Mosc). 1999;64:1326–1335
  30. Atalar E, Aytemir K, Haznedaroglu I, et al.  Platelet and leukocyte deactivation after intracoronary stent placement in patients receiving combined antiplatelet therapy. Clin. Appl. Thromb. Hemost. 2001;7:116–121
  31. Rupprecht HJ, Darius H, Borkowski U, et al.  Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. Circulation. 1998;97:1046–1052
  32. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165–2168
  33. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler. Thromb. Vasc. Biol. 2002;22:1769–1776
  34. Inoue T, Hoshi K, Yaguchi I, et al.  Serum levels of circulating adhesion molecules after coronary angioplasty. Cardiology. 1999;91:236–242
  35. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J. Am. Coll. Cardiol. 2000;35:157–163
  36. Woodburn KR, Lowe GD, Pollock JG, Rumley A, Reid AW. Percutaneous angioplasty, endothelial markers, and fibrin turnover. J. Endovasc. Surg. 1994;1:53–60
  37. Kennedy S, McPhaden AR, Wadsworth RM, Wainwright CL. Correlation of leukocyte adhesiveness, adhesion molecule expression and leukocyte-induced contraction following balloon angioplasty. Br. J. Pharmacol. 2000;130:95–103
  38. Schillinger M, Exner M, Mlekusch W, et al.  Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. Radiology. 2002;225:21–26

PII: S0021-9150(04)00233-3

doi: 10.1016/j.atherosclerosis.2004.03.024

Atherosclerosis
Volume 176, Issue 1 , Pages 125-132 , September 2004

Article Tools

* Image Usage & Resolution